Neurobo Pharmaceuticals Inc (NRBO) has fallen Friday morning, with the stock decreasing -7.75% in pre-market trading to 1.19. NRBO's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, the stock ranks higher than 56% of stocks. Neurobo Pharmaceuticals Inc has risen 7.50% over the past month, closing at $1.53 on November 25. During this period of time, the stock fell as low as $1.24 and as high as $2.33. NRBO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.
NRBO has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on NRBO!